Mosaic ($MOS) announced it has agreed to acquire Brazilian mining giant Vale’s fertilizer business for an aggregate purchase price valued at $2.5 billion.
Shares of Conatus Pharmaceuticals ($CNAT) are spiking higher in pre-market trading after the company announced a licensing agreement with Novartis ($NVS) for its liver disease treatment.
Biogen ($BIIB) announced the appointment of Michel Vounatsos as chief executive officer and a member of the Board of Directors, effective January 6, 2017. He will succeed George Scangos.
After the close of trading on Tuesday, athletic apparel and footwear giant Nike ($NKE) reported second quarter results that exceeded analyst estimates.
FedEx ($FDX) reported second quarter earnings that rose-year-over-year but came in below expectations. The delivery giant reported revenues that slightly exceeded estimates.
Home goods retailer Bed Bath & Beyond ($BBBY) reported third quarter results that came in below analyst estimates and said full-year earnings are expected to come in at the low end of guidance.
Micron ($MU) reported better than expected first quarter earnings on revenues that came in line with estimates. The chipmaker also provided upbeat second quarter guidance.
Lockheed Martin ($LMT) may come under pressure after President-elect Donald Trump said he asked Boeing (BA) to price-out a comparable F-18 Super Hornet due to the tremendous cost and cost overruns of the Lockheed Martin F-35.
Synergy Pharmaceuticals ($SGYP) announced positive results in the second of two phase 3 trials of plecanatide in patients with irritable bowel syndrome with constipation
Cintas ($CTAS) reported second quarter earnings of $1.13 per share compared to analyst estimates for $1.15 per share. Revenue for the quarter rose 6.6 percent to $1.30 billion.
$TSLA is now testing the 200 day moving average located around $214. Tesla (TSLA) is a strong buy below $170 going forward if we see the chart break down.